FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
, Dilip Davda and have given "Apply" recommendation to Laurus Labs IPO. recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 3 | 0 | 0 | 1 | 0 |
% | 75.00 | 0.00 | 0.00 | 25.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Apply | ||
Dilip Davda | Apply | |
Avoid | ||
Apply |
The Captial Market (CapitalMarket.com) rating for Laurus Labs IPO is 40. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 40 | Avoid, however active risk seekers can try |
[Dilip Davda] Company is having good contracts from world leaders and enjoys leadership position in APIs and generics. Investments made by the company will start adding to revenues and profits from FY 18 onwards and thus poised for bright prospects. Although issue appears to have been priced in line with peer’s trending, it may be considered for medium to long term investment. Read detail review...
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|